UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For
the month of August 2025
Commission
File Number: 001-42527
Basel
Medical Group Ltd
6
Napier Road,
Unit
#02-10/11 Gleneagles Medical Centre
Singapore
258499
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Resignation
of Chief Partnership Officer
Basel
Medical Group Ltd (Nasdaq: BMGL) (the “Company”) has received a letter of resignation from its Group Chief Partnership Officer,
Mr. Vincent Teo. The Company is presently determining the terms of separation with Mr. Teo. The Company would like to thank Mr. Teo for
his service to the Company during his tenure.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
| |
Basel Medical Group Ltd |
| |
|
|
| |
By: |
/s/ Darren
Yen Feng Chhoa |
| |
Name: |
Dr. Darren Yen Feng Chhoa |
| |
Title: |
Chief Executive Officer |
| |
|
|
| Date: August 13, 2025 |
|
|
